therapeutics
Document de presse
2021.05.12
Inserm teams led by Laurent Reber (Infinity, Toulouse) and Pierre Bruhns (Humoral Immunity, Institut Pasteur, Paris) and French company NEOVACS have developed...
News
2020.10.24
α1β2γ2 GABAA receptors mediate most inhibitory synaptic transmission in the brain, and are the target of widely used therapeutic drugs such as benzodiazepines...
News
2021.05.03
Free et Self-paced
Emerging and re-emerging viruses are key players among the different pathogens that have caused recent epidemics, as attested by several...
Document de presse
2020.07.01
The gut microbiota houses a complex and varied microbial community that coexists in a balance which is crucial for human health but poorly understood. In this...
News
2021.03.30
Immunotherapy, or the notion of "retraining" patients' immune systems, constitutes a major step forward in the fight against cancer. Although the results of...
News
2021.03.11
Two projects have been accepted into the Institut Pasteur Innovation Accelerator, an initiative to improve the development potential of the Institut Pasteur's...
News
2021.03.09
Bordetella pertussis is the agent responsible for whooping cough, a disease that is currently on the rise. In particular, the bacterium produces the CyaA toxin...
News
2021.02.08
Membrane vesicles (also known as extracellular vesicles) are produced by all kinds of organisms. They are small lipid bags that come off a donor cell and get...
Document de presse
2021.01.25
Since early 2020, the Institut Pasteur has been engaged in research in several of its areas of scientific expertise, including virology, diagnostics,...
News
2021.02.02
Cancer is the leading cause of mortality in France. In the last 40 years, survival rates have increased for several types of cancer, such as breast or prostate...